Verrica Pharmaceuticals Inc (VRCA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Verrica Pharmaceuticals Inc-Aktie (VRCA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	92.45% 3.826	1.988	2.917	0.182	0.037
Cost Of Revenue	250.00% 0.70	0.20	0.30	-	-
Gross Profit	74.83% 3.126	1.788	2.617	-	-
Operating Expenses	10.74% 22.43	25.12	26.83	11.80	7.126
Interest Income/Expense	0.61% 2.319	2.305	1.657	-	-
Benefits Costs and Expenses	9.19% 24.16	26.60	-	-	6.626
Costs And Expenses	9.19% 24.16	26.60	26.83	11.80	6.626
Operating Income/Loss	19.61% -18.60	-23.14	-23.92	-11.62	-7.089
Nonoperating Income/Loss	17.19% -1.732	-1.478	-0.885	0.626	0.50
Income/Loss From Continuing Operations Before Tax	17.40% -20.33	-24.61	2.917	-10.99	-6.589
Income/Loss From Continuing Operations After Tax	17.40% -20.33	-24.61	-24.80	-10.99	-6.589
Net Income/Loss	17.40% -20.33	-24.61	-24.80	-10.99	-6.589
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	14,135% 46.48	0.3266	46.07	45.92	43.02
Diluted Average Shares	14,135% 46.48	0.3266	46.07	45.92	43.02
Basic Earnings Per Share	18.52% -0.44	-0.54	-0.54	-0.24	-0.15
Diluted Earnings Per Share	18.52% -0.44	-0.54	-0.54	-0.24	-0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%